News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
317 Results
Type
Article (23)
Press Release (294)
Section
Business (106)
Deals (11)
Drug Development (76)
FDA (4)
Job Trends (3)
News (190)
Policy (16)
Tag
Academia (2)
Alliances (21)
Antibody-drug conjugate (ADC) (1)
Approvals (4)
Best Places to Work (3)
Cancer (9)
CAR-T (1)
Cell therapy (1)
Clinical research (58)
COVID-19 (1)
Data (4)
Diagnostics (3)
Earnings (59)
Events (59)
FDA (4)
GLP-1 (2)
Government (2)
Healthcare (5)
Infectious disease (1)
IPO (9)
Legal (1)
Lung cancer (3)
Medical device (1)
Medtech (1)
Mergers & acquisitions (2)
NextGen: Class of 2025 (1)
Pancreatic cancer (3)
People (29)
Phase I (36)
Phase II (18)
Phase III (18)
Pipeline (3)
Preclinical (14)
Regulatory (15)
Research institute (5)
Date
Last 7 days (1)
Last 30 days (3)
Last 365 days (27)
2025 (11)
2024 (23)
2023 (31)
2022 (48)
2021 (43)
2020 (32)
2019 (19)
2018 (14)
2017 (22)
2016 (17)
2015 (7)
2014 (12)
2013 (18)
2012 (6)
2011 (2)
2010 (1)
Location
Asia (15)
Europe (271)
Massachusetts (16)
North Carolina (1)
United States (17)
317 Results for "nanobiotix".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Nanobiotix to Participate in the H.C. Wainwright 3rd Annual BioConnect Investor Conference at NASDAQ
May 12, 2025
·
1 min read
Press Releases
NANOBIOTIX Provides Business Update and Reports Full Year 2024 Financial Results
April 3, 2025
·
16 min read
Press Releases
Nanobiotix Announces Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer
May 5, 2025
·
10 min read
Press Releases
NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025
March 31, 2025
·
2 min read
Press Releases
Nanobiotix Announces Presentation of Full Results From Completed Phase 1 Study Evaluating JNJ-1900 (NBTXR3) in Pancreatic Cancer Followed by a Conference Call
April 30, 2025
·
6 min read
Press Releases
Nanobiotix to Participate in Multiple Investor Conferences in February and March 2025
January 30, 2025
·
2 min read
Press Releases
NANOBIOTIX Announces Presentation of Data From Two Phase 1 Studies Evaluating JNJ-1900 (NBTXR3) at the European Lung Cancer Conference
March 20, 2025
·
6 min read
Press Releases
NANOBIOTIX Strengthens Financial Position Through Amendment of Global Licensing Agreement for JNJ-1900 (NBTXR3) and Extends Cash Visibility to Mid-2026
March 18, 2025
·
8 min read
Genetown
NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
NANOBIOTIX announced today that Company management will participate in a fireside chat at the upcoming Jefferies Global Healthcare Conference. Please see below for details of the event.
May 23, 2024
·
3 min read
Business
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
NANOBIOTIX provided an update on operational progress and reported financial results for the first quarter of 2024.
May 22, 2024
·
4 min read
1 of 32
Next
